Estimation of serum Tumor Necrosis Factor-α and tumor tissue superoxide dismutase (SOD) activity in the prognosis of human colorectal cancer

International Journal of Clinical Oncology

Volumn 2, Issue 1, 1997, Pages 15-20

  Satomi, Akira ^a   Murakami, Saburo ^a   Hashimoto, Taiju ^a   Okamura, Uima ^a   Okubo, Katsuhiko ^a   Takahashi, Shigeki ^a   Hirayama, Renzo ^a   Sonoda, Masaru ^a   Komoda, Tsugikatsu ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Neutrophils; Prognosis; Tissue SOD; TNF

Indexed keywords

EID: 0011060292     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02492592     Document Type: Article

References (31)

1. Phillip R, Epstein LB. Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, α-interferon and interleukin-4. Nature 1986;323:86-89.
2. Watanabe N, Umetsu T, Sone H, Neda H, Yamauchi N, Umeno H, Maeda M, Niitsu Y. Stimulation of antitumorigenic cytotoxicity in macrophages by tumor necrosis factor. Cancer J 1988;2:165-168.
3. Yamaguchi N, Kuriyama M, Watanabe N, Neda M, Maeda M, Niitsu Y. Intercellular hydroxyl radical production induced by recombination human tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res 1989;49:1671-1675.
4. McCord JM, Fridovich I. Superoxide dismutase. An enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244:6049-6055.
5. Kawaguchi T, Takeyasu A, Mastunobu K, Uda T, Ishizawa M, Suzuki K, Nishiura T, Ishikawa M, Taniguchi N. Stimulation of Mn-superoxide dismutase expression by tumor necrosis factor-α: quantitative determination of Mn-SOD protein levels in TNF-resistant and sensitive cells by ELISA. Biochem Biophys Res Com 1990;171:1378-1386.
6. Wong GHW, Goeddel DV. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 1988;242:9410-9414.
7. Wong GHW, Elwell JH, Oberley LW, Goeddel DV. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989;58:923-931.
8. Peetre C, Gullberg V, Nilsson E, Olsson I. Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. J Clin Invest 1986;78:694-700.
9. Takeda K, Iwamoto S, Sugimoto H, Takuma T, Kawtani N, Noda M, Masaki A, Morise H, Arimura H, Konno K. Identity of differentiation inducing factors and tumor necrosis factors. Nature 1986;323:338-340.
10. Hermanek P. Sobin LH (eds) International Union Against Cancer. TNM atlas. 4th ed. Staging for colorectal carcinoma. New York: Springer-Verlag, 1992:47-52.
11. Kamakura M, Kouno J, Hamazu T. Examination for function of granulocyte by flow-cytometry. Mod Med Lab 1991;19:731-736 (in Japanese).
12. Sonoda M, Asakuno G, Matsuki M, Satomi A, Ishida K, Sakagishi K. Radical trapping by PBN during reperfusion in rabbit gastric mucosa. Free Rad Res 1993;19:185-191.
13. Rosenberg SA. Immunotherapy and gene therapy of cancer. Cancer Res 1991;51:5074-5079.
14. Frei E, Springgs D. Tumor necrosis factor: still a promising agent. J Clin Oncol 1989;7:291-294.
15. Spriggs D, Imamura K, Rodriguez C, Horiguchi J, Kufe DW. Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. Proc Natl Acad Sci USA 1987;84:6563-6566.
16. Socher SH, Maritinez D, Craig JB, Kuhn JG, Oliff A. Tumor necrosis factor not detectable in patients with clinical cancer cachexia. J Natl Cancer Inst 1988;80:595-598.
17. Yamazaki M, Okutomi T. Augmentation of release of cytotoxin from murine bone marrow and peritoneal macrophages by tumor transplantation. Cancer Res 1989;49:352-356.
18. Calandra T, Baumgartner JD, Gru GE, Wu MM, Lambert PH, Schellekens J, Verhoet J, Glauser MP, Swiss-Dutch J5 Immunoglobulin Study Group. Prognostic values of tumor necrosis factor/cachectin interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock. J Infect Dis 1990;161:982-987.
19. Saji S, Umemoto T, Keshikama I, Tanemura H. Effects of neutrophils on cancer treatment. Tumor Infect 1990;3: 361-368 (in Japanese).
20. Inokuchi K, Inutsuka S, Furusawa M, Soejima K, Ikeda T. Stromal reaction around tumor and metastasis and prognosis after curative gastrectomy for carcinoma of stomach. Cancer 1967;20:1924-1929.
21. Ioachim HL. The stromal reaction of tumor: an expression of immune surveillance. J Natl Cancer Inst 1976;57:465-475.
22. Satomi A, Murakami S, Ishida K, Mastuki M, Hashimoto T, Sonoda M. Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncologica 1995;34:69-73.
23. Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML. Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor-α. Proc Natl Acad Sci USA 1990;87:6758-6761.
24. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin-8. J Exp Med 1991;173:771-774.
25. Nishioka Y, Sone S, Orino E, Nii A, Ogata T. Down-regulation by interleukin 4 of activation of human alveolar macrophages to the tumoricidal state. Cancer Res 1991;51:6683-6688.
26. Yamazaki M, Ikenami M, Sugiyama T. Cytotoxin from polymorphonuclear leukocytes and inflammatory ascitic fluids. Br J Cancer 1989;59:353-355.
27. Sykes JA, McCormack FX Jr, O Brien JJ. A preliminary study of the superoxide dismutase content of some human tumors. Cancer Res 1978;38:2759-2762.
28. Satomi A, Murakami S, Hashimoto T, Ishida K, Sonoda M. Significance of superoxide dismutase (SOD) on human colorectal cancer tissue; correlation with malignant intensity. J Gastroenterol 1995;30:177-182.
29. Zimmerman RJ, Marafino B Jr, Chan A, Lander P, Winkelhake JL. The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo. J Immunol 1989;142:1405-1409.
30. Fujii J, Taniguchi N. On the mechanism of the Mn-SOD gene expression in cancer cells. CRC 1992;11:108-115 (in Japanese).
31. Everaerdt B, Brouckaert P, Shaw A, Fiers W. Four different interleukin-1 species sensitize to the lethal action of tumour necrosis factor. Biochem Biophys Res Com 1989;163:378-385.